Shopping Cart
- Remove All
- Your shopping cart is currently empty
Trequinsin hydrochloride (HL 725) is a potent phosphodiesterase (PDE) inhibitor and inhibitor of platelet aggregation, and is a novel antihypertensive vasodilator for the study of cardiovascular disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | 102 € | In Stock | |
25 mg | 600 € | 6-8 weeks | |
50 mg | 780 € | 6-8 weeks | |
100 mg | 1.292 € | 6-8 weeks |
Description | Trequinsin hydrochloride (HL 725) is a potent phosphodiesterase (PDE) inhibitor and inhibitor of platelet aggregation, and is a novel antihypertensive vasodilator for the study of cardiovascular disease. |
Targets&IC50 | platelet cAMP phosphodiesterase (PDE):0.25 nM |
In vitro | In addition to its cardioprotective and antihypertensive effects, Trequinsin hydrochloride exhibits significant antiplatelet activity.Trequinsin hydrochloride is a potent inhibitor of platelet cAMP phosphodiesterase (PDE) with an IC50 of 0.25 nM. [1] In addition, Trequinsin hydrochloride is a potent calcium agonist. [3] |
Alias | HL 725 |
Molecular Weight | 441.95 |
Formula | C24H28ClN3O3 |
Cas No. | 78416-81-6 |
Smiles | Cl.O=C1N(C(=NC=2C(=CC(=CC2C)C)C)C=C3C=4C=C(OC)C(OC)=CC4CCN13)C |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 40 mg/mL (90.51 mM), Sonication is recommended. DMSO: 50 mg/mL (113.13 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.